an effective strategy to confer electroporation … · web viewelaboration of an electroporation...
TRANSCRIPT
Elaboration of an electroporation protocol for Bacillus cereus ATCC 14579.
Nathalie Turgeon1, Christian Laflamme1, Jim Ho2, Caroline Duchaine1,3*.
1 Institut universitaire de cardiologie et de pneumologie, Hôpital Laval, Université Laval,
Quebec City, Québec, Canada
2 Biological Detection Group, Defense Research and Development Canada Suffield, CFB
Suffield, Ralston, Alberta, Canada
3 Département de biochimie et microbiologie, Faculté des sciences et de génie,
Université Laval, Quebec City, Québec, Canada
* Corresponding author. Mailing address: Caroline Duchaine, Ph.D., Centre de recherche,
Hôpital Laval, 2725 Chemin Ste-Foy, Québec, Canada, G1V 4G5. Phone: (418) 656-
8711 ext. 5837. Fax: 418 656-4509. E-mail: [email protected]
1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
1
Abstract
An electro-transformation procedure was established for Bacillus cereus ATCC 14579.
Using early growth-stage culture and high electric field, the ectroporation efficiency was
up to 2X109 cfu µg-1ml-1 with pC194 plasmid DNA. The procedure was tested with three
other plasmids, of various sizes, replication mechanisms and selection markers, and the
transformation efficiencies ranged between 2X106 to 1X108 cfu µg-1ml-1. The effects of
two wall-weakening agents on electroporation rates were also evaluated. The
transformation rate reached with our procedure is 103 times higher than that previously
obtained with members of Bacillus genus with similar plasmids, and 106 times superior
than that achieved with available protocols for B. cereus. The proposed method is quick,
simple, efficient with small rolling circle plasmids and large theta replicating plasmids
with low copy number per cell, and suitable for many genetic manipulations that are not
possible without high efficiency transformation protocols.
Key words: Bacillus cereus, electroporation, glycine, threonine, wall-weakening.
2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
1
Introduction
Bacillus cereus is a gram positive sporulating bacterium commonly found in soil and air.
It is also an opportunistic pathogen that can induce food poisoning (Schoeni and Wong,
2005). Among the B. cereus group, B. cereus is closely related to B. thuringiensis, B.
mycoides and B. anthracis, the causative agent of anthrax (Ash et al., 1991).
Genetic manipulations are useful for various types of studies and applications (Sambrook
and Russell, 2001). DNA can be incorporated into Bacillus cells using several techniques
(cf. review by Bron and Vehmaanperä, 1990). Electroporation is quick and simple
compared to other methods, and results are highly reproducible. However, among
Bacillus species, different electroporation efficiencies have been reported due to the large
variability between methods (Bron and Vehmaanperä, 1990). In recent years, efforts have
been made to increase success rates up to 106 cfu µg-1 for B. subtilis using a combination
of osmoprotective agents and high electric fields (Xue et al., 1999). Similar findings have
been reported for B. pseudofirmus using osmolarity protection followed by treatment with
glycine and high electric field (Ito and Nagane, 2001). These strategies have not been
tested for members of B. cereus group. For B. cereus, the highest electroporation
efficiency is 103 cfu µg-1, being insufficient for many applications such as mutagenesis
(Belliveau and Trevors, 1989).
In the present study we evaluated the influence of modulating growth cycle, electric field
and amino-acid composition (glycine and threonine) to elaborate an electro-
transformation procedure of B. cereus ATCC 14579.
3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
Material and Methods
Bacterial strains, plasmids and media. Bacterial strains used in this study are
Escherichia coli MC1061 (Wertman et al., 1986), Bacillus cereus ATCC14579, B. cereus
HER-1399 and B. cereus HER-1414. E. coli MC1061 was grown in Luria broth (Difco
Laboratories, Detroit, MI) at 37C, 200 rpm. B. cereus was grown at 37C, 200 rpm in
trypticase soy broth (TSB) (Difco Laboratories) or on trypticase soy agar (TSA) (Difco
Laboratories). When appropriate, 100µg/ml of ampicilin or 20 µg/ml of tetracycline,
chloramphenicol or erythromicine (Sigma-Aldrich, Oakville, Ontario, Canada) were
added.
Plasmids used in this study are listed in table 1. Plasmidic DNA of pLS1 and pAM1 was
purified from E. coli MC1061 using Qiagen plasmid maxi kit (Qiagen, Chatsworth, CA).
For the isolation of pT181 from S. aureus and pC194 form B. subtilis, the purification
procedure was preceded by a lysostaphin treatment (25 ng/ml, 15 min, 37C) and a
lysozyme treatment (10mg/ml lysozyme, 30 min, 37C), respectively.
Preparation of electro-competent cells. B. cereus ATCC14579 cells growth was
monitored by measurement of optical density at 600nm using a GeneQuant pro UV/Vis
spectrophotometer (Biochrom Ltd, Cambridge England). When wall-weakening
treatment was performed, 5% glycine or DL-threonine and 250mM sucrose were added
during different stages of growth and incubated 1h, 2h or 3h, 37C, 200 rpm. Cells were
washed five times in electroporation buffer (250mM sucrose, 1mM Hepes, 1mM MgCl2,
4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
10% glycerol, pH 7,0) and concentrated 150-fold.
Electroporation. Electroporation was performed at 25 µF using a Bio-Rad Gene Pulser
apparatus (Bio-Rad laboratories) equipped with a Bio-Rad pulse controller.
Electroporation was carried out in 2mm cuvettes (Bio-Rad laboratories, Richmond, CA)
where 100µl cells were combined with 1µg DNA (voltage range up to 12.5kV cm -1) or in
1mm electroporation cuvettes with 50µl cells combined with 500ng plasmid, in order to
respect cells/DNA proportions (voltage range between 13 and 25kV cm-1). After
electroporation, cell suspensions were diluted with 1ml of TSB supplemented with
250mM sucrose, 5mM MgCl2, 5mM MgSO4 and incubated for 2h at 37C, 200 rpm to
allow expression of antibiotic resistance markers. Aliquots were spread onto tryptic soy
agar (TSA, Difco Laboratories) supplemented with either 20µg/ml tetracycline,
chloramphenicol or erythromycin (Sigma-Aldrich, Oakville, Ontario, Canada).
Transformants harboring antibiotic resistance were counted following overnight
incubation.
Statistical analyses. The statistical analyses were carried out with Statistical Analytical
Software (SAS). Results were expressed as mean value standard deviation. Data were
analyzed using paired t-test. All reported p-values were declared significant at p < 0.05.
5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1
Results and Discussion
Optimization of growth conditions. We transformed late stage cultures of B. cereus
with pLS1 using the electroporation protocol described by Vehmaanperä (Bron and
Vehmaanperä, 1990). The transformation efficiency was 103 cfu µg-1 ml-1 and is in
agreement with published findings.
Glycine was used to enhance electro-competence of B. cereus as previously described
(Hammes et al., 1973). For many species, the presence of the wall-weakening agent
glycine during bacterial growth improves the transformation rate (Framson et al., 1997;
Helmark et al., 2004; Lee et al., 2002; McDonald et al., 1995). Glycine is incorporated
into interpeptide bridges of peptidoglycan instead of L and D-alanine thereby reduces the
extent of cross-linking of the wall (Hammes et al., 1973). Unfortunately, in the presence
of glycine bacterial growth is highly variable (Buckley et al., 1999; Dunny et al., 1991).
To circumvent this problem, glycine was added to an exponentially growing culture in
order to maximize the effects without compromising cell growth. This method has
previously been used for cryotransformation of B. anthracis (Stepanov et al., 1990) and
electroporation of lactic acid bacteria, streptococci and B. pseudofirmus (Buckley et al.,
1999; Ito and Nagane, 2001; Mason et al., 2005; Turgeon and Moineau, 2001).
Wall-weakening treatments strongly affect the growth of B. cereus. In 10% glycine, total
cellular lysis occurred within one hour even if sucrose was added as isotonic agent. With
5% glycine, the OD remained nearly stable for at least an hour (data not shown). To
6
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
determine the optimal growth stage and incubation time suitable for B. cereus, glycine
and sucrose were added during different stages of growth (Figure 1). Cells were
incubated for 0h, 1h, 2h, or 3h with glycine prior to washing in electroporation buffer and
electroporation with pLS1 DNA, at 12.5 kV cm-1, 200 .
For most of the tested conditions (Figure 1), cells collected in early-stage gave better
electroporation rates than late-stage culture. Treatment with glycine for 1 or 2h provided
similar data; however, with 3h glycine treatment results were highly variable due to cell
lysis in the samples. Under these experimental conditions, optimal results (3X105 cfu µg-1
ml-1) were obtained in early growth stage culture (O.D. 0.2 - 0.5) at 1h incubation with
glycine (Figure 1).
Optimization of electroporation conditions. Electroporation parameters were further
optimized as follows. Experiments were performed with pLS1 DNA using the optimal
growth parameters defined in the previous section (O.D. 0.2 - 0.4 with 1h incubation in
glycine-sucrose). Electroporation parameters were set as shown in Figure 2. The best
transformation efficiency was obtained using high electric field at 200, 20kV cm-1.
Transformation efficiency declined markedly at higher voltages. Using this procedure, a
transformation efficiency of 9X105 cfu µg-1 ml-1 was obtained for B. cereus.
Comparison with other studies. To validate the procedure and to compare results with
other studies, transformation with plasmid pC194 was tested. This plasmid has the same
replication mechanism and a similar size than pUB110 (McKenzie et al., 1986), the
7
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
plasmid used in B. subtilis and B. pseudofirmus where transformation efficiencies of 106
cfu µg-1 have been achieved. The transformation rate obtained using our procedure (O.D.
0.2-0.5, 1h incubation with 5% glycine, 20 kV cm-1, 200Ω) was 5X108 cfu µg-1 ml-1 with
pC194 plasmid DNA (compared to 9X105 cfu µg-1 ml-1 with pLS1 DNA). This result is
100 times greater than that obtained in earlier studies with other Bacillus sp. using
osmolarity protection, glycine treatment, high electric field and pUB110 DNA (Ito and
Nagane, 2001; Xue et al., 1999). Bacterial growth during the 2h of recovery after
electroporation cannot be responsible of this enhancement because a 2h or 3h of recovery
was used in previous studies (Ito and Nagane, 2001; McDonald et al., 1995; Xue et al.,
1999).
Comparison of wall-weakening treatments. Previous studies document that DL-
threonine is an effective wall-weakening agent for B. subtilis (McDonald et al., 1995).
We compared the effects of DL-threonine and glycine as described above. Furthermore,
to determine the influence of wall-weakening treatment on electroporation rates,
replicates of the procedure were done and statistical analyses were performed. Cells were
grown until OD 0.2-0.4 was reached and collected without treatment or incubated 1h with
5% glycine or DL-threonine and 250mM sucrose. OD was monitored during wall-
weakening treatment to ensure that cellular lysis did not occur. Experiments were done
using three different cell batches. Electroporation treatments were performed three to six
times for each cell lot as described previously, with pC194 plasmid DNA and high
electric field (25 µF, 20 kV cm-1, 200Ω). The greatest transformation efficiencies were
obtained in the absence of wall-weakening agent (control) and were up to 2X109 cfu µg-1
8
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
ml-1 compared with 5X108 cfu µg-1 ml-1 for glycine treatment and 2X108 cfu µg-1 ml-1 for
DL-threonine treatment (Figure 3). To our knowledge, this level of electro-competence is
the highest ever achieved for the Bacillus genus.
Paired T-test performed on data from all experimental conditions documented a
significant and reproducible difference (p 0.05). Under these conditions, DL-threonine
reduced the transformation rates of B. cereus by 50% compared to glycine-treatment, and
glycine reduced the transformability by 71% compared to untreated cells. Wall-
weakening treatment did not improve transformation rates with pLS1 DNA either (data
not shown). Thus, it is apparent that under weak electric field, glycine positively affects
transformation rate (Figure 1). With high electric field, the presence of wall-weakening
agents decreases electro-transformability of B. cereus (Figure 3). As such, glycine and
DL-threonine treatment does not confer a positive effect on transformation rate or reduce
the overall burden of work. Consequently, we would recommend use of the
electroporation protocol without addition of wall weakening agents.
Transformation efficiencies with various strains plasmids. Many factors influence
transformation efficiency, namely size and replication mechanism of the plasmid used.
We compared the electroporation efficiencies obtained with four different plasmids,
harboring various size, selection marker, copy number per cell and replication mechanism
(Table 2). The highest results were obtained with the smallest plasmid harboring a
chloramphenicol selection marker (pC194). High electroporation efficiency was also
obtained with the larger plasmid carrying an erythromycin resistance gene
9
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
(pMTL500Eres). The lowest transformation rates were obtained with plasmids containing
tetracycline resistance marker. In this case, for the same plasmid size, the plasmid with a
high copy number (pT181) gave better results than the plasmid with a low copy number
(pLS1).
Those results showed that chloramphenicol and erythromycin are more suitable selection
markers for the electro-transformation of B. cereus. With the appropriate selection
marker, the described electroporation protocol gave high transformation efficiencies,
even for large theta replicating plasmids with low copy number per cell (Table 2).
Interesting results were also obtained with two other strains of B. cereus (6X106 ufc µg-1
ml-1 with HER-1399 and 3X106 ufc µg-1 ml-1 with HER-1414 with pC194 DNA). Those
results are 103 times superior than previously reported for B. cereus strains. Therefore,
this protocol can increase the electro-transformation efficiencies for several strains of B.
cereus, but growth and electroporation parameters should be adapted to each specific
strain, as previously reported for other bacterial species (Buckley et al., 1999).
This paper describes an electro-transformation method for Bacillus cereus ATCC14579
with results of 2X109 cfu µg-1 ml-1; this level of transformation is the highest ever
reported for Bacillus sp. The method is quick, simple, highly reproducible, appropriate
for many plasmids and suitable for many genetic manipulations that are not possible
without high efficiency transformation protocols. In addition, this procedure may be
useful for other Bacillus strains that are refractory to electroporation.
10
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1
Acknowledgements
We are very grateful to Gloria del Solar, Marie-Françoise Noirot-Gros, Sleem Khan and
Laurent Jannière for generous provision of the pLS1, pC194, pT181 and pMTL500Eres
plasmids. We also acknowledge Felix d’Hérelle Reference Center for Bacterial Viruses
for providing B. cereus strains HER-1399 and HER-1414. We thank the members of the
Groupe de recherche en santé respiratoire for helpful discussions. NT is the recipient of a
postdoctoral fellowship from the Groupe de recherche en santé respiratoire. CD
acknowledges a CIHR/IRSST scholarship. This work was funded by Defense Research
and Development Canada Suffield.
11
1
2
3
4
5
6
7
8
9
10
1
References
Ash, C., Farrow, J.A., Dorsch, M., Stackebrandt, E., Collins, M.D., 1991. Comparative analysis of Bacillus anthracis, Bacillus cereus, and related species on the basis of reverse transcriptase sequencing of 16S rRNA. Int. J. Syst. Bacteriol. 41, 343-346.
Belliveau, B.H., Trevors, J.T., 1989. Transformation of Bacillus cereus vegetative cells by electroporation. Appl. Environ. Microbiol. 55, 1649-1652.
Bron, S., Vehmaanperä, J., 1990. Electrotransformation of B. amyloliquefaciens/B. subtilis. In Molecular biological methods for Bacillus, pp. 156-157. Edited by Harwood, C., Cutting, S. Chichester: John Wiley and sons.
Buckley, N.D., Vadeboncoeur, C., LeBlanc, D.J., Lee, L.N., Frenette, M., 1999. An effective strategy, applicable to Streptococcus salivarius and related bacteria, to enhance or confer electroporation competence. Appl. Environ. Microbiol. 65, 3800-3804.
Dunny, G.M., Lee, L.N., LeBlanc, D.J., 1991. Improved electroporation and cloning vector system for gram-positive bacteria. Appl. Environ. Microbiol. 57, 1194-1201.
Framson, P.E., Nittayajarn, A., Merry, J., Youngman, P., Rubens, C.E., 1997. New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl. Environ. Microbiol. 63, 3539-3547.
Hammes, W., Schleifer, K.H., Kandler, O., 1973. Mode of action of glycine on the biosynthesis of peptidoglycan. J. Bacteriol. 116, 1029-1053.
Helmark, S., Hansen, M.E., Jelle, B., Sorensen, K.I., Jensen, P.R., 2004. Transformation of Leuconostoc carnosum 4010 and evidence for natural competence of the organism. Appl. Environ. Microbiol. 70, 3695-3699.
Horinouchi, S., Weisblum, B., 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150, 815-825.
Ito, M., Nagane, M., 2001. Improvement of the electro-transformation efficiency of facultatively alkaliphilic Bacillus pseudofirmus OF4 by high osmolarity and glycine treatment. Biosci. Biotechnol. Biochem. 65, 2773-2775.
Khan, S.A., Novick, R.P., 1983. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 10, 251-259.
Lacks, S., Lopez, P., Greenberg, B., Espinosa, M., 1986. Identification and analysis of genes for tetracycline resistance and replication functions in the broad-host-range plasmid pLS1. J. Mol. Biol. 192, 753-765.
12
1
23456789
101112131415161718192021222324252627282930313233343536373839404142434445
1
Lee, S.H., Cheung, M., Irani, V., Carroll, J.D., Inamine, J.M., Howe, W.R., Maslow, J.N., 2002. Optimization of electroporation conditions for Mycobacterium avium. Tuberculosis 82, 167-174.
Mason, C.K., Collins, M.A., Thompson, K., 2005. Modified electroporation protocol for Lactobacilli isolated from the chicken crop facilitates transformation and the use of a genetic tool. J. Microbiol. Methods 60, 353-363.
McDonald, I.R., Riley, P.W., Sharp, R.J., McCarthy, A.J., 1995. Factors affecting the electroporation of Bacillus subtilis. J. Appl. Bacteriol. 79, 213-218.
McKenzie, T., Hoshino, T., Tanaka, T., Sueoka, N., 1986. The nucleotide sequence of pUB110: some salient features in relation to replication and its regulation. Plasmid 15, 93-103.
Sambrook, J., Russell, D.W., 2001. Molecular cloning: a laboratory manual, 3 edn. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
Schoeni, J.L., Wong, A.C., 2005. Bacillus cereus food poisoning and its toxins. J. Food Prot. 68, 636-648.
Stepanov, A.S., Puzanova, O.B., Dityatkin, S., Loginova, O.G., Ilyashenko, B.N., 1990. Glycine-induced cryotransformation of plasmids into Bacillus anthracis. J. Gen. Microbiol. 136, 1217-1221.
Swinfield, T.J., Janniere, L., Ehrlich, S.D., Minton, N.P., 1991. Characterization of a region of the Enterococcus faecalis plasmid pAM beta 1 which enhances the segregational stability of pAM beta 1-derived cloning vectors in Bacillus subtilis. Plasmid 26, 209-221.
Turgeon, N., Moineau, S., 2001. Isolation and characterization of a Streptococcus thermophilus plasmid closely related to the pMV158 family. Plasmid 45, 171-183.
Wertman, K.F., Wyman, A.R., Botstein, D., 1986. Host/vector interactions which affect the viability of recombinant phage lambda clones. Gene 49, 253-262.
Xue, G.-P., Johnson, J.S., Dalrymple, B.P., 1999. High osmolarity improves the electro-transformation efficiency of the gram-positive bacteria Bacillus subtilis and Bacillus licheniformis. J. Microbiol. Methods 34, 183-191.
13
123456789
1011121314151617181920212223242526272829303132333435363738394041
1
Table 1Plasmids used in this studyPlasmid Relevant characteristics ReferencespC194 Staphylococcus aureus, Cmr, 2.9 kb (Horinouchi and Weisblum, 1982)pLS1 Streptococcus agalactiae, pMV158 mob derivative, Tcr, 4.4 kb (Lacks et al., 1986)pMTL500Eres Enterococcus faecalis, pAM1 derivative, Ampr, Emr, 7.1 kb (Swinfield et al., 1991)pT181 Staphylococcus aureus, Tcr, 4.4 kb (Khan and Novick, 1983)Note. Ampr, ampicilin resistance; Cmr, chloramphenicol resistance; Emr, erythromycin resistance; Tcr, tetracycline resistance
14
12
3
1
Table 2Transformation efficiencies obtained with various plasmidsPlasmids Plasmid
copy numberReplication mechanism
Size(kb)
Antibioticselection
Transformationefficiencies
pC194 Medium RC 2.9 Cm 8X108
pLS1 Low RC 4.4 Tc 2X106
pT181 High RC 4.4 Tc 8X106
pMTL500Eres Low 7.1 Em 1X108
Note. , theta replication mechanism; Cm, chloramphenicol; Em, erythromycin; RC, rolling circle replication mechanism; Tc, tetracycline
15
12
34
1
Figure 1. Relationship between numbers of transformants obtained per microgram of
pLS1 DNA and per milliliter of competent cells and cell density. Cells were grown until
the optical density indicated was obtained and then further incubated with glycine for 0h
(), 1h (), 2h (), and 3h (). Electroporations were performed with low electric field
(200 , 12.5 kV cm-1).
16
1
2
3
4
5
6
7
1
Figure 2. Optimization of electroporation parameters. Relationship between numbers of
transformants obtained per microgram of pLS1 DNA and per milliliter of competent cells
and voltage. Electroporations were performed in early growth stage cultures (O.D. 0.2-
0.4) incubated for 1h glycine, at the voltages indicated and at resistance levels of 100
(), 200 () or 400 ().
17
1
2
3
4
5
6
7
1
Figure 3. Comparison of different wall-weakening treatments with untreated cells.
Transformation rates obtained with pC194 DNA under high electric field (200 , 20 kV
cm-1) with 3 different batches (, , ) of untreated cells (control), glycine treated, and
DL-threonine treated cells. Standard deviation and p-value are displayed on the graphic.
18
1
2
3
4
5
1